| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.01 |